Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Crovalimab by Chugai Pharmaceutical for Sickle Cell Disease With Vaso-Occlusive Crisis: Likelihood of Approval
Crovalimab is under clinical development by Chugai Pharmaceutical and currently in Phase II for Sickle Cell Disease With Vaso-Occlusive Crisis....